Keefe, Bruyette & Woods Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price

Globe Life (NYSE:GL) had its target price increased by Keefe, Bruyette & Woods from $160.00 to $162.00 in a research note released on Tuesday morning, Marketbeat reports. They currently have an outperform rating on the stock.

GL has been the topic of a number of other research reports. Cfra Research raised shares of Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Truist Financial boosted their target price on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Friday. BMO Capital Markets restated a “market perform” rating and set a $149.00 target price (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Wells Fargo & Company lowered their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Finally, Morgan Stanley set a $179.00 target price on shares of Globe Life and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $153.56.

Globe Life Stock Performance

Shares of GL stock opened at $134.33 on Tuesday. The company’s fifty day simple moving average is $139.47 and its 200-day simple moving average is $129.82. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. The firm has a market cap of $10.88 billion, a PE ratio of 9.73 and a beta of 0.55. Globe Life has a 12 month low of $100.27 and a 12 month high of $147.83.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 22.12%. During the same quarter in the previous year, the firm posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities research analysts expect that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, October 3rd. Globe Life’s payout ratio is currently 7.83%.

Insider Buying and Selling at Globe Life

In related news, EVP Michael Clay Majors sold 10,000 shares of the company’s stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $137.41, for a total value of $1,374,100.00. Following the transaction, the executive vice president directly owned 47,066 shares in the company, valued at approximately $6,467,339.06. This represents a 17.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the company’s stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the transaction, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This trade represents a 27.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.97% of the stock is owned by insiders.

Hedge Funds Weigh In On Globe Life

Several institutional investors and hedge funds have recently modified their holdings of GL. AdvisorNet Financial Inc raised its stake in Globe Life by 60.0% during the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 84 shares during the period. Amalgamated Bank grew its holdings in Globe Life by 0.5% during the 1st quarter. Amalgamated Bank now owns 16,348 shares of the company’s stock valued at $2,153,000 after buying an additional 85 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in Globe Life by 1.1% during the 1st quarter. Venturi Wealth Management LLC now owns 8,226 shares of the company’s stock valued at $1,084,000 after buying an additional 93 shares in the last quarter. HighPoint Advisor Group LLC grew its holdings in Globe Life by 4.2% during the 1st quarter. HighPoint Advisor Group LLC now owns 2,366 shares of the company’s stock valued at $293,000 after buying an additional 95 shares in the last quarter. Finally, Intech Investment Management LLC grew its holdings in Globe Life by 0.8% during the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after buying an additional 95 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.